Connect with us:   Email This Page  | Print
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy<sup>®</sup> System

Current Procedural Terminology (CPT)1
Several CPT codes may be used for reporting the various services related to the delivery of TMS therapy. For the NeuroStar TMS Therapy procedure itself, Category I CPT Codes are available effective January 1, 2011. The American Medical Association (AMA) has elevated the current Category III “T” Codes (0160T and 0161T) for TMS to the following Category I CPT Codes.2

Table 3. NeuroStar TMS Therapy Category I CPT Codes
CPT Code Description
90867 Therapeutic repetitive transcranial magnetic stimulation treatment; planning

(Report only once per course of treatment.)
(Do not report in conjunction with 95928, 95929.)
90868 Therapeutic repetitive transcranial magnetic stimulation treatment; delivery and management, per session

Code Usage: The AMA created CPT code 90867 to report treatment planning services during the initial patient visit. This includes determining the patient's cortical neuron excitability or motor threshold (MT) value, determining and storing the cortical landmark coordinates corresponding to the location were MT was determined, determining and storing the treatment location coordinates, and selecting and storing treatment parameters for a given treatment protocol. CPT code 90868 was created to report services for each session when treatment is delivered and patient management services are provided. Thus, for the initial visit (day one of TMS Therapy) when a treatment planning session is completed and a treatment delivery session is completed, both 90867 and 90868 should be reported. On subsequent treatment days, when only treatment delivery and management is provided, only 90868 would be reported. Example: If the course of TMS Therapy for a given patient consisted of 26 treatments, 90867 would be reported once and 90868 would be reported 26 times for that patient for this course of therapy.

The Federal Register issued on November 2, 2010 provides the AMA’s decision to elevate the TMS codes to Category I status. It states that the CPT I codes for TMS for CY 2011 will not include physician work and practice expense RVUs. As a result, the TMS codes will be contractor priced.

Payers will typically manually review codes without Relative Value Units (RVUs) to confirm coverage and reimbursement rates for the services provided. To complete this review, the provider may need to submit documentation to the payer describing the services provided, the technology used, and the reasoning behind the treatment (e.g., letter of medical necessity). The AMA notes, “Pertinent information should include an adequate definition or description of the nature, extent, and need for the procedure and the time, effort, and equipment necessary to provide the service. ”4 Providers should contact individual payers directly to verify the appropriate code(s) for reporting NeuroStar TMS Therapy and claim documentation requirements.

View the Reference Coding Guide for Coding of NeuroStar TMS Therapy

If operating in a hospital, click here to view the Hospital Coding Reference Guide.

References:
  1. Current Procedural Terminology (CPT® 2011), Professional Edition, American Medical Association, 2010. CPT is a Registered Trademark of the American Medical Association.
  2. Current Procedural Terminology (CPT® 2011), Professional Edition, American Medical Association, 2010. 457
  3. Federal Register, November 2, 2010, Vol. 75, No. 211 (557).
  4. Current Procedural Terminology (CPT® 2011), Professional Edition, American Medical Association, 2010, xvi

Please Note: The information contained provided is for educational purposes only. It is intended to assist providers in accurately obtaining reimbursement for healthcare services. It is not intended to increase or maximize reimbursement by any payer. We strongly suggest that you consult the specific payer with regard to local reimbursement policies. The information, including all CPT® & HCPCS billing codes, contained in this guide represents no statement, promise or guarantee by Neuronetics concerning levels of reimbursement, payment, or charge. It is always the provider’s responsibility to determine and submit appropriate codes for the services rendered.

Refer a Patient for Treatment
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider

Become a NeuroStar TMS Therapy Provider
Provide your patients the new way back from depression with NeuroStar TMS Therapy®. Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us


* NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information

Copyright © 2012 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary
 

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.